Furthermore, PVT1 has shown to decrease miR-195 and miR-200b expression in cervical cancer either by enhancing histone H3K27me3 in the miR-195 and miR-200b promoters or by direct binding of miR-195 and miR-200b (154, 155). Here, PVT1 is linked to cervical carcinoma.